Watch On:
Summary
Digital pathology has become increasingly common among European healthcare providers, and the technology is now gaining traction in the U.S. Because this market is poised for expeditious growth, leading technology vendors are competing for dominance. The digital pathology imaging management systems made by Leica Biosystems and Philips seem to be leading the pack in this competitive market, according to a KLAS report published last week. In fact, a handful of providers included in the survey are already conducting more than half of their pathology work digitally.
Show Notes
The digital pathology imaging management systems made by Leica Biosystems and Philips seem to be leading the pack in this competitive market, according to a KLAS report published last week.
Thirty-three of these providers have gone live with digital pathology, and the remaining 21 are currently implementing plans to adopt it in the near future.
Among the providers that have already adopted digital pathology, all of them are using it with histological slides.
The majority of providers (64%) that have implemented digital pathology are using it for primary diagnosis.
A full 96% of providers that use digital pathology said the technology has met or exceeded their expectations for quality improvement.
